DETERMINATION OF THE KINETIC CONSTANTS OF TISSUE FACTOR/FACTOR VII/FACTOR VIIA AND ANTITHROMBIN/HEPARIN USING SURFACE PLASMON RESONANCE

By Bjorquist P.   Bostrom S.  

Thrombosis Research, Vol. 85, Iss. 3, 1997-02 ,pp. : 225-236

Elsevier

Access to resources Recommend Favorite

Structural Requirements of Human Tissue Factor Pathway Inhibitor (TFPI) and Heparin for TFPI-Heparin Interaction - Proposed heparin recognition region

By Ye Z.   Takano R.   Hayashi K.   Ta T.-V.   Kato H.   Kamikubo Y.   Nakahara Y.   Kumeda K.   Hara S.  

Thrombosis Research, Vol. 89, Iss. 6, 1998-03 ,pp. : 263-270

Elsevier

Access to resources Recommend Favorite

Differential Effects of Low Molecular Weight Heparin and Unfractionated Heparin on Circulating Levels of Antithrombin and Tissue Factor Pathway Inhibitor (TFPI) - Insight into its possible mechanism of action

By Hansen J.-B.   Sandset P.M.  

Thrombosis Research, Vol. 91, Iss. 4, 1998-08 ,pp. : 177-181

Elsevier

Access to resources Recommend Favorite

SYNTHETIC PEPTIDE ANALOGS OF TISSUE FACTOR AND FACTOR VII WHICH INHIBIT FACTOR Xa FORMATION BY THE TISSUE FACTOR/FACTOR VIIa COMPLEX

By Ronning H.F.   Risoen U.C.   Orning L.   Sletten K.   Sakariassen K.S.  

Thrombosis Research, Vol. 84, Iss. 2, 1996-10 ,pp. : 73-81

Elsevier

Access to resources Recommend Favorite

Inhibitory Properties of Human Recombinant Arg 24 ->Gln Type-2 Tissue Factor Pathway Inhibitor (R24Q TFPI-2) - The relationship between intermolecular association with factor VIIa and enzymatic activity of the complex

By Kamei S.   Petersen L.C.   Sprecher C.A.   Foster D.C.   Kisiel W.  

Thrombosis Research, Vol. 94, Iss. 3, 1999-05 ,pp. : 147-152

Elsevier

Access to resources Recommend Favorite